Clinical Trials on 波特综合症 in Korea, Democratic People's Republic of
总计927个结果
-
Unimed Pharmaceuticals完全的
-
Hanmi Pharmaceutical Company Limited终止
-
Korea University完全的Metabolic Syndrome, Atherosclerosis大韩民国
-
Yonsei University完全的共有 234 名急性冠状动脉综合征患者将接受 OPCAB。大韩民国
-
Seoul National University HospitalChong Kun Dang Pharmaceutical完全的
-
Yonsei UniversityEwha Womans University Mokdong Hospital完全的
-
Gachon University Gil Oriental Medical HospitalDongGuk University; Sangji University Oriental Medical Hospital, Korea完全的
-
Gachon University Gil Oriental Medical HospitalDongGuk University; Kyunghee University Medical Center; Wonkwang University Guangju Medical Center 和其他合作者完全的
-
Korea University完全的
-
Chungnam National UniversityNational Research Foundation, Singapore完全的
-
ICAN Nutrition Education and ResearchCalifornia Walnut Commission完全的
-
Seoul National University HospitalChong Kun Dang Pharmaceutical完全的
-
Seoul National University HospitalJW Pharmaceutical未知
-
Ajou University School of MedicineDong-A Pharmaceutical完全的
-
Yonsei University完全的
-
Korea University Anam HospitalAstraZeneca完全的
-
Dong-A UniversityAstraZeneca; Biotronik SE & Co. KG完全的
-
The Catholic University of KoreaSoonchunhyang University Hospital完全的
-
AJU Pharm Co., Ltd.OM Pharma SA招聘中
-
Laboratoires TheaSamil Pharmaceutical Co., Ltd.完全的